news & events
By Kristen Bole
For the second year in a row, UC San Francisco’s four schools topped the nation in federal biomedical research funding in their fields in 2014, with the university as a whole receiving the most of any public recipient in NIH funds.
Full story | Sidebar: 2014 NIH Funding: A Look at Top Recipients (February 26, 2015)
By Marilynn Marchione
For the first time, a study shows that a drug used to treat HIV infection also can help prevent it when taken before and after risky sex by gay men.
Full story (subscription required) in San Francisco Chronicle (February 24, 2015)
By Erin Allday
Deborah Cohan reached peak Internet fame a few days after her double mastectomy. In the minutes leading up to her surgery, Cohan led her team of doctors and nurses in a Beyoncé dance party that was captured on video.
Full story in San Francisco Chronicle (February 21, 2015)
By Caroline Chen
Gilead Sciences Inc. may be one of the first drugmakers in history to have people asking why it’s not doing more to pitch its medicine.
Full story in Bloomberg Business (February 17, 2015)
By Laura Dudnick
When it comes to one of the world’s deadliest epidemics, Dr. Paul Volberding knows better than anyone how important San Francisco has been in the fight against HIV and AIDS.
Full story in the San Francisco Examiner (February 10, 2015)
By Mitchel Williams
Poppy and Ted Morgan may seem like your everyday, ordinary couple. But their story is far from ordinary. Ted is HIV-positive, and Poppy is not.
Video on America with Jorge Ramos/Fusion (December 23, 2014)
By Jerome Groopman
Ward 86, the nation’s first outpatient AIDS clinic, opened at San Francisco General Hospital on January 1, 1983. Recently, I went there to see Steven Deeks, an expert on the chronic immune activation and inflammation brought on by HIV.
Full story in the New Yorker (December 22, 2014)
By Mehroz Baig
On this year's World AIDS Day, San Francisco's Getting to Zero Coalition unveiled a draft strategic plan, which aims to make San Francisco the first jurisdiction with zero new HIV infections, zero stigma and zero deaths.
Full story on Huffington Post (December 10, 2014)
By Ron Leuty
The good news: A pill from Gilead Sciences Inc. stops HIV infection among people at high risk of contracting the AIDS virus. The bad news: Men taking the drug to prevent HIV appear to be having more sex without a condom.
Full story in San Francisco Business Times (December 8, 2014)
By Alice Park
San Francisco was ground zero for HIV in the U.S. Now it wants to be the first city in the world with no new infections, no stigma—and no deaths.
Full story in TIME (November 20, 2014) (registration required)
By Matthew Bajko
San Francisco leaders have mapped out an aggressive plan to cut new HIV infections by 90 percent come 2020. The ultimate goal is to get to no new HIV infections.
Full story in the Bay Area Reporter (November 11, 2014)
By Eric Goosby
I was training fellows in HIV/AIDS care at San Francisco General Hospital's Ward 86 when I heard the news that Joep Lange had perished on Malaysian Airlines flight MH17, which was shot down Thursday over Ukraine.
Full op-ed in San Francisco Chronicle (July 20, 2014)
UCSF Global Health Sciences statement (July 18, 2014)
Bay Area AIDS leaders mourn loss of colleagues on Malaysian flight
By Erin Allday and Hamed Aleaziz, San Francisco Chronicle (July 18, 2014)
At least 6 AIDS researchers on board Malaysia Flight 17, not 100 as originally feared
By Elissa Harrington, ABC Channel 7 News (July 19, 2014)
AIDS researcher Joep Lange confirmed among dead in Malaysia jet shoot-down
By Joel Achenbach and Ariana Cha, Washington Post (July 17, 2014)
Pioneering AIDS researcher Lange was a star with a passion to help
By Eryn Brown and Christine Mai-Duc, Chicago Tribune (July 19, 2014)
Prominent AIDS Researcher Dies
By Tracy Vence, The Scientist (July 18, 2014)
By Jeff Sheehy
New research from UCSF shows that an “expressive therapy” group intervention...helps women living with HIV disclose their health status and improves their social support, self-efficacy and the safety and quality of their relationships.
Full UCSF story (July 11, 2014)
Related story by Erin Allday in San Francisco Chronicle (July 11, 2014)
By Bob Roehr
A single injection might allow sexually active people to throw away the condoms and be completely protected from HIV infection for up to three months. This form of PrEP could be a reality in as little as five years, say researchers.
Full story in Bay Area Reporter (July 3, 2014)
By Anand Veeravagu, MD
What if it was our own genetic code that was responsible for inviting HIV into the life of a cell cycle?...If you burn the invitation, do you prevent transmission or replication?
Full story on The Daily Beast (June 11, 2014)
By Erin Allday
When Adam Zeboski started using the HIV drug Truvada in November 2012, he was HIV-free himself, but in a relationship with a man who had been infected.
Full story in San Francisco Chronicle (June 3, 2014)
By Rueben Kramer
Undetectable. If you have HIV, that's as good as it gets. It means the amount of human immunodeficiency virus in your body is so low that it can't be detected by a standard blood test...but it's still there, in trace amounts, hiding in blood and tissue.
Full story in Philadelphia Inquirer (May 18, 2014)
By Ariana Eunjung Cha
When Susan Hartmann got married, she and her husband knew that they had to be careful. Given that she’s HIV-negative and he’s HIV- positive, they had to be vigilant about protected sex. But later, they decided they wanted to start a family.
Full story in Washington Post (April 24, 2014)
By Erin Allday
Methamphetamine users who focus on cutting back or practicing safer methods of getting high—instead of trying to quit the drug altogether—are also able to reduce risky sexual behaviors that can make them vulnerable to HIV.
Full story in San Francisco Chronicle (April 18, 2014)
UCSF story by Jeff Sheehy (April 18, 2014)
Michael Krasny's Forum on KQED Radio features UCSF's Oliver Bacon, Dominika Seidman, and Jeff Sheehy in a discussion on PrEP.
Listen on KQED (April 17, 2014)
By Jorge Ramos
Max Cameron and Andy Clements have been dating for more than a year. The two are living the dream in San Francisco, but they are not like every other couple, they are in a serodiscordant relationship. Max is HIV-negative, and Andy is HIV-positive.
Video on America with Jorge Ramos (April 15, 2014)
By Monte Morin
Researchers studying the effects of immune suppressant drugs on transplant patients with HIV have made a surprising discovery: A drug intended to hobble the body's defense system may actually help destroy dormant reservoirs of the virus that causes AIDS.
Full story in Los Angeles Times (April 4, 2014)
By Bernadette Tansey
Looking back on that drive to find the first HIV drugs, the task seems relatively simple to Romas Geleziunas—at least, compared to the problem he’s tackling now.
Full story in Xconomy (March 24, 2014)
Melissa Chan reporting
In the battle against HIV/AIDS, the numbers are still alarming. According to the Centers for Disease Control, 50,000 people are newly infected every year.
Video on Al Jazeera America (March 20, 2014)
Once again, University of California, San Francisco (UCSF), ranks #1 among medical schools in the US for its AIDS programs according to US News & World Report, as it has every year since the category was created in 2001.
Top-ranked schools in AIDS and overall rankings for UCSF in US News & World Report (March 11, 2014)
Related story in UCSF News (March 11, 2014)
For years, we have been told that condoms are critical in stopping the spread of HIV, the virus that causes AIDS. A new study suggests some gay men may not need them.
Full story on KPIX-TV (March 6, 2014)
San Francisco AIDS Foundation has appointed Dr. Robert Grant as its first-ever chief medical officer, the nonprofit announced.
Full story in the Bay Area Reporter (March 6, 2014)
By Erin Allday
Scientists safely implanted into HIV-positive patients immune cells that were genetically modified to resist the virus, and the effect for a few of those patients was a decrease in the amount of virus found in their blood—even after they went off drugs that control their infection.
Full story in the San Francisco Chronicle (March 5, 2014)
By Donald G. McNeil Jr.
When scientists made the stunning announcement last year that a baby born with HIV had apparently been cured through aggressive drug treatment just 30 hours after birth, there was immediate skepticism that the child had been infected in the first place. But on Wednesday, the existence of a second such baby was revealed at an AIDS conference here, leaving little doubt that the treatment works.
Full story in the New York Times (March 5, 2014)
By Jon Cohen
Antiretroviral drugs can protect people from becoming infected by HIV. But so-called pre-exposure prophylaxis, or PrEP, only works if people take pills daily—which studies show they have trouble doing. Now, monkey experiments with an integrase inhibitor that's injected show how a single shot protects them from the AIDS virus for 11 weeks on average.
Full story in Science (March 4, 2014)
By Marilynn Marchione
Exciting research suggests that a shot every one to three months may someday give an alternative to the daily pills that some people take now to cut their risk of getting HIV.
Full story in Yahoo! News (March 4, 2014)
By Jeremy Lybarger
The city that was once the deadly AIDS epicenter of the world is now striving to be AIDS-free. What does that mean, and why is San Francisco poised to achieve this goal the way no other American city could?
Full story in the Advocate (March 3, 2014)
From White House Recommendations to Community Action: Addressing the Intersections of Trauma, Violence, Women and HIV
The White House Office of National AIDS Policy showed their love for women by formally launching the recommendations report of the Federal Interagency Workgroup on the Intersection of HIV/AIDS, Violence Against Women and Girls, and Gender-Related Health Disparities.
Positive Women’s Network–USA press release (February 14, 2014)
The battle against AIDS, which began in the early 1980s and has succeeded in finding treatments to control the disease, is increasingly turning to a different phase: the hunt for a real and complete cure.
Full story on PBS Newshour (February 7, 2014)
By David Heitz
Some people contract HIV and never get sick. These people are called “controllers,” and studying them has long been a focus for researchers seeking a cure for the disease.
Full story in Healthline News (February 7, 2014)
The AIDS Research Institute at UCSF is proud to announce that Willi McFarland, MD, PhD, MPH&TM, has been awarded the 2013-2014 ARI Award for Outstanding Teaching and Mentoring.
Full announcement (PDF) (February 6, 2014)
Two HIV positive patients, believed to have been cured, have tested positive again, but scientists say they are inspired to continue research.
Full story in Mail & Guardian (January 2, 2014)
By David Tuller
Michael Rubio recalled how four friends became HIV positive through unprotected sex, all within a year. The news shocked Mr. Rubio, a 28-year-old gay man, into trying a controversial new form of HIV prevention: a daily pill that studies show is highly effective in protecting people from infection.
Full story in the New York Times (December 30, 2013)
By Erin Allday
Dr. Eric Goosby started his medical career just as the AIDS epidemic was emerging in San Francisco. Now he's come home, a doctor and a diplomat defined both by his earliest exposures to the devastation of AIDS, and by the hard-fought campaigns he's championed on a global scale.
Full story in the San Francisco Chronicle (December 25, 2013)
Monday, December 2, 2013
Getting to Zero in San Francisco: How Close Are We?
Rainbow Room, LGBT Community Center
1800 Market St., San Francisco
Sponsored by UCSF HIV/AIDS Division at SFGH, SF AIDS Foundation, Project Inform, SFGH, AIDS Research Institute at UCSF
Video of event
By Laura Kurtzman
At UCSF’s Global Health Sciences, Goosby will lead a new center on implementation sciences, a hot, new field in public health and an emerging specialty at UCSF. It examines the practicalities of running public health programs, applying business-world efficiencies to improve them.
Full story in UCSF News (November 25, 2013)
By Gillian Mohney
The HOPE act signed by President Barack Obama on Thursday will allow HIV positive organs to be used in organ transplants by HIV positive recipients, creating a larger pool of organs for transplants.
Full story on ABC World News (November 22, 2013)
By Geoffrey Mohan
The search-and-destroy mission against the HIV virus just got much more complicated. New research suggests that HIV's genetic program is far more abundant in certain dormant T-cells of infected patients and is potentially more capable of unleashing its deadly instructions than previously thought.
Full story in LA Times (October 24, 2013)
By Liz Highleyman
Nearly 100 people gathered at the State Building in San Francisco on Tuesday to hear the latest news on HIV cure research, a field that has seen remarkable, if slow, progress over the past few years. The town hall featured researchers from three collaborative efforts funded by the NIH to work on various cure approaches.
Full story in Bay Area Reporter (October 3, 2013)
By Erin Allday
In the race for a cure for HIV, the wins are stacking up. Through a variety of mechanisms and treatments, individuals were able to shake the virus and stop taking the drugs that HIV-infected patients ordinarily need to survive. They represent possibility - that modern science is capable of curing a deadly infection.
Full story in SF Gate (October 1, 2013)
By Carolyn Johnson
Researchers at San Francisco's Gladstone Institutes are being awarded more than $12 million in grants from divisions of the National Institutes of Health to help develop an elusive knock-out punch against AIDS.
Full story in ABC (September 30, 2013)
By Benjamin Ryan.
Organizers at the AIDS Policy Project have tapped October 5 as the first annual "AIDS Cure Day." With a goal of far-reaching political mobilzation in mind, the agency is organizing participants across the country and around the globe to help them spread the word about where we are in the complex effort to outfox the virus.
Full story in POZ (September 29, 2013)
By Donald G. McNeil Jr.
Recent work by Dr. Picker, a vaccine expert at Oregon Health & Science University, has shaken up the long, frustrating search for an AIDS vaccine. His latest study, published in Nature last week, has scientists scratching their heads, wondering if it might open up a new avenue for research.
Full story in NY Times (September 16, 2013)
See Archive for older stories